<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>During pregnancy, the changes of cardiovascular <z:mp ids='MP_0001532'>physiology</z:mp> can impose additional load and risk on the cardiovascular system of women with <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Care of women with <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> and childbearing potential should include preconception risk stratification and counselling </plain></SENT>
<SENT sid="2" pm="."><plain>Risk stratification rests on a carefully obtained history and examination, electrocardiography and echocardiography </plain></SENT>
<SENT sid="3" pm="."><plain>Exercise capacity is an important predictor of maternal cardiovascular events </plain></SENT>
<SENT sid="4" pm="."><plain>High-risk conditions include severe <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo>, <z:mp ids='MP_0001575'>cyanotic</z:mp> lesions, severe left ventricular obstruction and <z:e sem="disease" ids="C0003493" disease_type="Disease or Syndrome" abbrv="">aortic disease</z:e> in <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan-Syndrome</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>High-risk patients should be referred to and cared for by tertiary centres </plain></SENT>
<SENT sid="6" pm="."><plain>A multidisciplinary team approach with cardiologists, obstetricians and anaesthetists during pregnancy, delivery and the postpartum period is recommended </plain></SENT>
<SENT sid="7" pm="."><plain>Meticulous attention should be paid to effective anticoagulation for prosthetic heart valves </plain></SENT>
<SENT sid="8" pm="."><plain>Risks and benefits of the anticoagulation strategy should be fully discussed with the patient </plain></SENT>
<SENT sid="9" pm="."><plain>Peripartal <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> is a disease that occurs during he late stages of pregnancy and the peripartum period and is associated with <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo>, thrombembolism, cardiac <z:hpo ids='HP_0011420'>death</z:hpo> and recurrence in subsequent pregnancies </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0001644'>Dilated cardiomyopathy</z:hpo> with impaired functional reserve or markedly <z:hpo ids='HP_0005162'>impaired left ventricular function</z:hpo> constitutes a high risk for the pregnant women </plain></SENT>
<SENT sid="11" pm="."><plain>In addition to <z:chebi fb="199" ids="26708">sodium</z:chebi> restriction, treatment of <z:hpo ids='HP_0001635'>heart failure</z:hpo> consists of loop <z:chebi fb="40" ids="35498">diuretics</z:chebi>, <z:chebi fb="1" ids="35620">vasodilators</z:chebi>, digoxin and beta-blockers, if appropriate </plain></SENT>
<SENT sid="12" pm="."><plain><z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">Coronary heart disease</z:e> and <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> are rare during pregnancy but should be considered in women with <z:hpo ids='HP_0100749'>chest pain</z:hpo> </plain></SENT>
<SENT sid="13" pm="."><plain>Pharmacological therapy of rhythm disorders should be reserved for <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> resulting in maternal or fetal hemodynamic compromise and for <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> with intolerable symptoms </plain></SENT>
</text></document>